Kriya Therapeutics is a biopharmaceutical company focused on developing gene therapies for common diseases in ophthalmology, neurology, and metabolic disorders. With operations in Palo Alto and Research Triangle Park, the company has raised over $450 million to advance its pipeline of therapies.
Kriya Therapeutics Highlights:
Overview
- Website: kriyatherapeutics.com
- Headquarters: Palo Alto, California
- Employees: 200
- Founded: 2019
- Email: info@kriyatx.com
- Funding: $618.0M
- Revenue: $28.0M
- Valuation: n/a
Contacts
- Email: ***@kriyatherapeutics.com
Similar companies
Frequently Asked Questions related to Kriya Therapeutics
Kriya Therapeutics is located in Palo Alto, California.
Yes, Kriya Therapeutics is a Silicon Valley company.
Kriya Therapeutics total funding is 618.0M.
Kriya Therapeutics revenue is 28.0M.
Kriya Therapeutics’s number of employees is 200.
Kriya Therapeutics’s CEO name is Shankar Ramaswamy.
Kriya Therapeutics was founded in 2019.
Kriya Therapeutics’s contact email is info@kriyatx.com.
